Back
Acumen Pharmaceuticals Vs. Janux Therapeutics Industry Stock Comparison
Sell
34
ABOS
Acumen Pharmaceuticals
Last Price:
2.26
Seasonality Move:
2.47%
Sell
34
JANX
Janux Therapeutics
Last Price:
66.94
Seasonality Move:
133.13%
Sell
34
Acumen Pharmaceuticals (ABOS)
is a Sell
Is Acumen Pharmaceuticals a Buy, Sell or Hold?
- The current Acumen Pharmaceuticals [ABOS] share price is $2.28. The Score for ABOS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- ABOS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $59.86. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABOS Stock Price Chart
What is Acumen Pharmaceuticals's stock price today?
-
The Acumen Pharmaceuticals share price today is $2.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABOS is experiencing selling pressure, which indicates risk of future bearish movement.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $59.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
ABOS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 40.84 | Sell |
Chaikin Money Flow: | -110345 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.29 - 3.01) | Sell |
Bollinger Bands (100): | (2.36 - 3.02) | Sell |
JANX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 63.62 | Buy |
Chaikin Money Flow: | -6955717 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.07 - 55.53) | Buy |
Bollinger Bands (100): | (41.63 - 51.75) | Buy |
ABOS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.3 | Sell |
20-day SMA: | 2.58 | Sell |
50-day SMA: | 2.57 | Sell |
200-day SMA: | 3.03 | Sell |
8-day EMA: | 2.33 | Sell |
20-day EMA: | 2.47 | Sell |
50-day EMA: | 2.57 | Sell |
200-day EMA: | 2.98 | Sell |
JANX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.16 | Buy |
20-day SMA: | 50.4 | Buy |
50-day SMA: | 49.88 | Buy |
200-day SMA: | 44.87 | Buy |
8-day EMA: | 49.16 | Buy |
20-day EMA: | 49.72 | Buy |
50-day EMA: | 49.41 | Buy |
200-day EMA: | 41.75 | Buy |
Acumen Pharmaceuticals Earnings Growth & ABOS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and a decrease next year of $0.04 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.91 per share.
Acumen Pharmaceuticals Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Janux Therapeutics Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |